Steven Cohen Landec Corp \Ca\ Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	N/A	-141,446 Closed	0 $0
Q4 2022 Feb 14, 2023	SELL	$0.0 - $9.95 $0 - $445,342	-44,758 Reduced 24.04%	141,446 $0
Q3 2022 Nov 14, 2022	SELL	$8.57 - $11.57 $149,940 - $202,428	-17,496 Reduced 8.59%	186,204 $1.66 Million
Q2 2022 Aug 15, 2022	SELL	$8.84 - $11.64 $511,447 - $673,443	-57,856 Reduced 22.12%	203,700 $2.03 Million
Q1 2022 May 16, 2022	BUY	$10.07 - $11.93 $851,287 - $1.01 Million	84,537 Added 47.76%	261,556 $3.03 Million
Q4 2021 Feb 14, 2022	BUY	$7.95 - $11.24 $1.41 Million - $1.99 Million	177,019 New	177,019 $1.97 Million

20.4M

65.8K

14.1K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.